HKMPF
Price
$21.86
Change
-$0.01 (-0.05%)
Updated
Sep 26 closing price
Capitalization
4.85B
HYPMY
Price
$4.62
Change
+$0.22 (+5.00%)
Updated
Sep 26 closing price
Capitalization
2.73B
Interact to see
Advertisement

HKMPF vs HYPMY

Header iconHKMPF vs HYPMY Comparison
Open Charts HKMPF vs HYPMYBanner chart's image
Hikma Pharmaceuticals
Price$21.86
Change-$0.01 (-0.05%)
Volume$1.22K
Capitalization4.85B
Hypera SA
Price$4.62
Change+$0.22 (+5.00%)
Volume$3.95K
Capitalization2.73B
HKMPF vs HYPMY Comparison Chart in %
Loading...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HKMPF vs. HYPMY commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKMPF is a Hold and HYPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (HKMPF: $21.86 vs. HYPMY: $4.62)
Brand notoriety: HKMPF and HYPMY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HKMPF: 101% vs. HYPMY: 6%
Market capitalization -- HKMPF: $4.85B vs. HYPMY: $2.73B
HKMPF [@Pharmaceuticals: Generic] is valued at $4.85B. HYPMY’s [@Pharmaceuticals: Generic] market capitalization is $2.73B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKMPF’s FA Score shows that 1 FA rating(s) are green whileHYPMY’s FA Score has 2 green FA rating(s).

  • HKMPF’s FA Score: 1 green, 4 red.
  • HYPMY’s FA Score: 2 green, 3 red.
According to our system of comparison, HYPMY is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPF’s TA Score shows that 3 TA indicator(s) are bullish while HYPMY’s TA Score has 6 bullish TA indicator(s).

  • HKMPF’s TA Score: 3 bullish, 5 bearish.
  • HYPMY’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, HYPMY is a better buy in the short-term than HKMPF.

Price Growth

HKMPF (@Pharmaceuticals: Generic) experienced а -0.38% price change this week, while HYPMY (@Pharmaceuticals: Generic) price change was +2.10% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($4.86B) has a higher market cap than HYPMY($2.73B). HYPMY has higher P/E ratio than HKMPF: HYPMY (21.07) vs HKMPF (13.09). HYPMY YTD gains are higher at: 57.271 vs. HKMPF (-6.287). HYPMY has higher annual earnings (EBITDA): 1.41B vs. HKMPF (734M). HYPMY has more cash in the bank: 1.2B vs. HKMPF (236M). HKMPF has less debt than HYPMY: HKMPF (1.56B) vs HYPMY (8.86B). HYPMY has higher revenues than HKMPF: HYPMY (6.66B) vs HKMPF (3.22B).
HKMPFHYPMYHKMPF / HYPMY
Capitalization4.86B2.73B178%
EBITDA734M1.41B52%
Gain YTD-6.28757.271-11%
P/E Ratio13.0921.0762%
Revenue3.22B6.66B48%
Total Cash236M1.2B20%
Total Debt1.56B8.86B18%
FUNDAMENTALS RATINGS
HKMPF vs HYPMY: Fundamental Ratings
HKMPF
HYPMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7982
PRICE GROWTH RATING
1..100
8550
P/E GROWTH RATING
1..100
969
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (8) in the null industry is in the same range as HYPMY (12). This means that HKMPF’s stock grew similarly to HYPMY’s over the last 12 months.

HKMPF's Profit vs Risk Rating (100) in the null industry is in the same range as HYPMY (100). This means that HKMPF’s stock grew similarly to HYPMY’s over the last 12 months.

HKMPF's SMR Rating (79) in the null industry is in the same range as HYPMY (82). This means that HKMPF’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's Price Growth Rating (50) in the null industry is somewhat better than the same rating for HKMPF (85). This means that HYPMY’s stock grew somewhat faster than HKMPF’s over the last 12 months.

HYPMY's P/E Growth Rating (9) in the null industry is significantly better than the same rating for HKMPF (96). This means that HYPMY’s stock grew significantly faster than HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HKMPFHYPMY
RSI
ODDS (%)
Bullish Trend 3 days ago
33%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
40%
Bearish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
37%
Bullish Trend 3 days ago
61%
MACD
ODDS (%)
Bearish Trend 3 days ago
32%
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
32%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
11%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
26%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJHRX31.070.63
+2.07%
PGIM Jennison Health Sciences R
FLOWX19.260.23
+1.21%
Fidelity Water Sustainability
SVFAX82.320.94
+1.16%
Smead Value A
CECYX30.080.22
+0.74%
Columbia Large Cap Enhanced Core Inst3
CICEX65.890.29
+0.44%
American Funds Invmt Co of Amer 529E

HKMPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HKMPF has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HKMPF jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
-0.06%
EBS - HKMPF
34%
Loosely correlated
+1.95%
IRWD - HKMPF
22%
Poorly correlated
+9.45%
AMPH - HKMPF
22%
Poorly correlated
+1.86%
GRUSF - HKMPF
8%
Poorly correlated
-8.37%
HYPMY - HKMPF
7%
Poorly correlated
+5.00%
More

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and HKMPY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and HKMPY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+5.00%
HKMPY - HYPMY
14%
Poorly correlated
+4.46%
KHTRF - HYPMY
8%
Poorly correlated
N/A
JUSHF - HYPMY
8%
Poorly correlated
+0.05%
HKMPF - HYPMY
7%
Poorly correlated
-0.06%
IPSEY - HYPMY
7%
Poorly correlated
-6.02%
More